Trials / Completed
CompletedNCT01310985
A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 14 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
Detailed description
Its a pilot study of pre-op chemotherapy and RT utilizing CAPECITABINE, XRT and CETUXIMAB in pts with locally advanced rectal carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®) | Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2011-03-09
- Last updated
- 2019-03-01
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01310985. Inclusion in this directory is not an endorsement.